Innovative application of allosteric modulators of adenosine a1 receptors for the prevention and treatment of stroke and myocardial infarction

Informations projet

KOUROUNAKIS ANGELIKI

N° de convention de subvention: QLK6-CT-1999-51170

Projet clôturé

Date de début 17 Janvier 2000

Date de fin 16 Janvier 2001

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 51 600,00

Contribution de l’UE € 51 600,00

Coordonné par

ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece

Objectif

Evaluation of a novel series of allosteric modulators, compounds that enhance adenosine A1 agonist binding and function, in combination with antioxidants, in in-vitro/in-vivo models of ischemic-reperfusion injury.

Champ scientifique

• medical and health sciences › basic medicine › neurology › stroke

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

ARISTOTLE UNIVERSITY OF THESSALONIKI

• Contribution de l’UE: Aucune donnée
• Adresse: University Building Administration Building ; 54006 THESSALONKI ; Grèce
• Coût total: Aucune donnée